VSee Health, Inc.

VSEE Healthcare Health Information Services

VSee Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 40.3% from fiscal 2024.

Revenue
−53.9%
EPS
+109.9%
Free cash flow
−257.6%
Total debt
+31.6%

Quarter to June 2026, against a year earlier

1.15 0.00 0.00%
Market cap
$2.8M
P/E
0.0×
Fwd P/E
−2.2×
Dividend yield
—
F-score
4/9
Altman Z
−6.06
Beneish M
−4.22
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
4 4 — —

+8 more TTM periods

ROE
(1,065.78%) (945.70%) (541.52%) 2,466.75%
ROA
(56.62%) (69.53%) (69.39%) (46.05%)
ROIC
(93.65%) (116.45%) (602.00%) 0.00%
Return on Tangible Assets
209.77% 199.66% 193.99% 52.22%
Average Days of Receivables
64.48 67.44 55.96 65.24
Free Cash Flow per Share
(9.40) (9.21) (13.86) (21.93)
Free Cash Flow
(6.31) (5.52) (3.49) (4.54)
Capital Expenditures
— (0.06) (0.05) (0.04)
Other line items
Cash ROIC
(71.43%) (65.31%) (31.46%) 100.53%
Accounts Receivable Turnover
6.56 6.39 7.39 5.56
Accounts Payable Turnover
1.08 0.86 0.78 0.52
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
269.01 401.06 468.95 828.44
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.01) 0.00 0.22 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
143.74% 120.50% 115.87% 106.19%
Share Based Compensation of Revenue
7.95% 8.12% 7.69% 8.02%
Interest Coverage
(5.78) (4.89) (3.41) (5.83)
Operating CF/Net income
0.64 0.41 0.23 0.45
Depreciation/Fixed assets
23.09 9.94 9.00 6.48
Capex/Depreciation
0.00 (0.02) (0.02) (0.02)
Revenue per Share
18.83 24.14 58.06 69.73
Operating CF per Share
(9.40) (9.11) (13.68) (21.72)
Capex per Share
0.00 (0.10) (0.18) (0.21)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates · fundamentals updated 2 Nov 2026